共查询到20条相似文献,搜索用时 8 毫秒
1.
Cyclin E is a target of WT1 transcriptional repression 总被引:5,自引:0,他引:5
Loeb DM Korz D Katsnelson M Burwell EA Friedman AD Sukumar S 《The Journal of biological chemistry》2002,277(22):19627-19632
2.
Sipina LV Bukurova YA Nikitina IG Krasnov GS Sergeev SA Lisitsyn NA Karpov VL Beresten SF 《Biochemistry. Biokhimii?a》2010,75(9):1148-1152
A modified method of proteome comparative analysis based on preliminary removal of cell structural proteins by extraction
using salt buffer and subsequent separation of extracts by two-dimensional gel electrophoresis was developed. Identification
of differentially expressed proteins by mass spectrometry has revealed three proteins with noticeably increased level of synthesis
in most samples of papillary thyroid tumors compared to normal tissues. An increase in ubiquitin content was found for the
first time. Oncomarker search efficiencies by two-dimensional gel electrophoresis and bioinformatic search were compared. 相似文献
3.
4.
5.
6.
7.
8.
9.
10.
Papillary thyroid carcinoma (PTC) represents an example of tumour with high incidence of oncogenic sequences, such as RET/PTC and Trk. Both of them arise from the fusion of 3' terminal sequences of TK domain of RET or NTRK1 gene, respectively, with 5' terminal sequences of their activating genes. In case of NTRK1 oncogene, several rearrangement types are observed, characteristic for PTC: Trk (TMP3), Trk-T1, Trk-T2, Trk-T3 and Trk-2h, observed in human breast cancer cell line. Studies from different geographical regions, revealed significant population differences in the incidence of Trk rearrangements (0-50%), while within the same population, the frequency of Trk in spontaneous and radiation-associated PTCs is similar. The results of studies, focused on the correlation between tumour genotype and the histopathological type of tumour, involving cases of both RET/PTC and Trk rearrangements in PTC, are not unequivocal. In many studies, no correlation was observed between the presence of RET and/or NTRK1 rearrangement and such parameters, as patient's age at diagnosis, gender, histopathological type of tumour or clinical stage (TNM stage grouping), although the earliest clinical symptoms and the worst disease outcomes were observed for RET/NTRK1 rearrangement positive tumours. Differences in the rearrangement incidence between male and female patients were associated with the latency period of radiation-associated tumours, being significantly lower in women. In general, it is assumed that oncogenic Trk sequences are typical for the spontaneous type of PTC. 相似文献
11.
12.
13.
14.
15.
16.
Alessandra Alteri Francesca De Vito Graziella Messina Monica Pompili Attilio Calconi Paolo Visca Marcella Mottolese Carlo Presutti Milena Grossi 《Cell cycle (Georgetown, Tex.)》2013,12(24):3781-3790
miR-206, a member of the so-called myomiR family, is largely acknowledged as a specific, positive regulator of skeletal muscle differentiation. A growing body of evidence also suggests a tumor suppressor function for miR-206, as it is frequently downregulated in various types of cancers. In this study, we show that miR-206 directly targets cyclin D1 and contributes to the regulation of CCND1 gene expression in both myogenic and non-muscle, transformed cells. We demonstrate that miR-206, either exogenous or endogenous, reduces cyclin D1 levels and proliferation rate in C2C12 cells without promoting differentiation, and that miR-206 knockdown in terminally differentiated C2C12 cells leads to cyclin D1 accumulation in myotubes, indicating that miR-206 might be involved in the maintenance of the post-mitotic state. Targeting of cyclin D1 might also account, at least in part, for the tumor-suppressor activity suggested for miR-206 in previous studies. Accordingly, the analysis of neoplastic and matched normal lung tissues reveals that miR-206 downregulation in lung tumors correlates, in most cases, with higher cyclin D1 levels. Moreover, gain-of-function experiments with cancer-derived cell lines and with in vitro transformed cells indicate that miR-206-mediated cyclin D1 repression is directly coupled to growth inhibition. Altogether, our data highlight a novel activity for miR-206 in skeletal muscle differentiation and identify cyclin D1 as a major target that further strengthens the tumor suppressor function proposed for miR-206. 相似文献
17.
18.
19.
20.